Relationship Between Medical Affairs, Market Access And Commercial
Though medical affairs must remain non-promotional, success in pharma today depends on collaboration. When medical, market access, and commercial teams align science with strategy, they ensure ethical marketing, accurate claims, and stronger market credibility. Read how synergy drives success.
While medical affairs operate in a strictly non-promotional environment, there has to be cooperation between market access, commercial and medical affairs, even though each department has its own defined tasks.
Indeed, while there is a clear distinction between medical affairs and commercial operations, there is a need for the two to work together, particularly at a strategic level.
Medical affairs within this context can support marketing messages by identifying and collecting the data to prove commercial statements, such as having the best-in-class drug for a particular disease. Medical affairs can further promote the commercial need by using facts and science.
It is worth remembering that drug marketing must be guided medically and can only be driven by scientific data. Within the distribution of marketing material, medical affairs also act as a control mechanism, avoiding the external spreading of incorrect statements and the use of publications of disputable quality for commercial claims.
This kind of internal firewall helps to ensure that there will not be any legal complications by stating concepts which are not proven or not true. Similar changes are observed in the collaborative relationship between medical affairs and market access.
Medical affairs and market access were two distinguished groups…
Create an account to continue reading
Create AccountAlready have an account? Sign in
Need an expert in this space?
Talk to an Industry Expert
Knowledge Ridge connects decision-makers with carefully vetted subject matter experts for one-on-one calls, research sprints, and advisory engagements — across 11 sectors and 163 sub-industries globally.
Comments
No comments yet. Be the first to comment!